These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Does sputum culture affect the management and/or outcome of community-acquired pneumonia? Shariatzadeh MR; Marrie TJ East Mediterr Health J; 2009; 15(4):792-9. PubMed ID: 20187530 [TBL] [Abstract][Full Text] [Related]
63. Antibiotic therapy for community-acquired pneumonia. Mandell LA Clin Chest Med; 1999 Sep; 20(3):589-98, ix. PubMed ID: 10516906 [TBL] [Abstract][Full Text] [Related]
64. Novel agents for the treatment of outpatient respiratory tract infections. Introduction. Pell DM Postgrad Med; 2002 Sep; 112(3 Suppl):5-6. PubMed ID: 19667592 [No Abstract] [Full Text] [Related]
65. CMS releases new standards for community-acquired pneumonia. Golden WE; Brown P; Godsey N J Ark Med Soc; 2003 Mar; 99(9):288-9. PubMed ID: 12674913 [No Abstract] [Full Text] [Related]
66. Worldwide guidelines for respiratory tract infections: community-acquired pneumonia. Dalhoff K Int J Antimicrob Agents; 2001; 18 Suppl 1():S39-44. PubMed ID: 11574194 [TBL] [Abstract][Full Text] [Related]
67. [Guidelines for management of community acquired pneumonia in children(the revised edition of 2013) (II)]. ; Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):856-62. PubMed ID: 24484563 [No Abstract] [Full Text] [Related]
71. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Mandell LA; Wunderink RG; Anzueto A; Bartlett JG; Campbell GD; Dean NC; Dowell SF; File TM; Musher DM; Niederman MS; Torres A; Whitney CG; ; Clin Infect Dis; 2007 Mar; 44 Suppl 2(Suppl 2):S27-72. PubMed ID: 17278083 [No Abstract] [Full Text] [Related]
72. Value of rapid aetiological diagnosis in optimization of antimicrobial treatment in bacterial community acquired pneumonia. Mareković I; Plecko V; Boras Z; Pavlović L; Budimir A; Bosnjak Z; Puretić H; Zele-Starcević L; Kalenić S Coll Antropol; 2012 Jun; 36(2):401-8. PubMed ID: 22856222 [TBL] [Abstract][Full Text] [Related]
73. Neonatal community-acquired pneumonia: pathogens and treatment. Wang H; Tang J; Xiong Y; Li X; Gonzalez F; Mu D J Paediatr Child Health; 2010 Nov; 46(11):668-72. PubMed ID: 20796185 [TBL] [Abstract][Full Text] [Related]
74. Modulating treatment according to resistance patterns and local epidemiology. J Assoc Physicians India; 2013 Jul; 61(7 Suppl):32-7. PubMed ID: 24779156 [No Abstract] [Full Text] [Related]
75. Diagnosis and treatment of community-acquired pneumonia in children. Korppi M Acta Paediatr; 2012 Jul; 101(7):702-4. PubMed ID: 22372540 [No Abstract] [Full Text] [Related]
76. [Comparative analysis of guidelines for the treatment of community-acquired pneumonias]. Rodríguez de Castro F Arch Bronconeumol; 1999 Jun; 35(6):253-6. PubMed ID: 10410203 [No Abstract] [Full Text] [Related]
77. [Community-acquired infections of the respiratory tract and lung parenchyma. Clinical and experimental aspects]. Rosseau S; Suttorp N Internist (Berl); 2000 Nov; 41(11):1158, 1161-9. PubMed ID: 11127219 [No Abstract] [Full Text] [Related]
78. Limitations of diagnostic testing in the initial management of patients with community-acquired pneumonia. San Pedro GS; Campbell GD Semin Respir Infect; 1997 Dec; 12(4):300-7. PubMed ID: 9436957 [TBL] [Abstract][Full Text] [Related]
79. Why should we measure bacterial load when treating community-acquired pneumonia? Waterer G; Rello J Curr Opin Infect Dis; 2011 Apr; 24(2):137-41. PubMed ID: 21301334 [TBL] [Abstract][Full Text] [Related]
80. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood]. Ouchi K Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]